Table 1 Pharmacological therapy of SSc patients at inclusion
Medication | Number of patients | % |
|---|---|---|
ARB/ACE inhibitors | 21 | 75 |
Calcium channel blockers | 16 | 57 |
Beta blockers | 8 | 29 |
Corticosteroids | 9 | 32 |
Pentoxifylline | 23 | 82 |
Nitroglycerine | 4 | 14 |
Vitamin E | 8 | 29 |
Platelet Aggregation Inhibitors | 16 | 57 |
H2-receptor blockers or proton-pump inhibitors | 14 | 50 |
Immunosuppressive agents | 3 | 11 |
NSAIDs | 5 | 18 |
Bisphosphonates | 3 | 11 |
Others (diuretics, tramadol, benzodiazepines, bronchodilators) | 14 | 50 |